Rheumatic Connective Tissue Diseases

  • J. T. Lie


The terms rheumatic connective tissue diseases and collagen-vascular diseases are synonymous, both referring to a large heterogeneous group of immunologically mediated inflammatory disorders (Table 21-1). In this chapter, emphasis is directed to a discussion of pulmonary involvement in nine selected rheumatic connective tissue disorders: rheumatic fever, rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), dermatomyositis-polymyositis (DPM), mixed connective tissue disease (MCT), Sjögren syndrome, ankylosing spondylitis (AS), and relapsing polychondritis (RP) (Table 21-2).


Systemic Lupus Erythematosus Pulmonary Hypertension Systemic Lupus Erythematosus Patient Interstitial Lung Disease Systemic Sclerosis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Klinge F. Der Rheumatismus. Pathologisch-anatomische und experimentell-pathologische Tatsachen und ihre Auswertung für das änztliche Rheumaproblem. Ergeb Allg Pathol 1933; 27: 1–351.Google Scholar
  2. 2.
    Klinge F. Zur pathologischen Anatomie des Rheumatismus. Verh Dtsch Orthop Ges 1934; 28: 44–50.Google Scholar
  3. 3.
    Klemperer P, Pollack AD, Baehr G. Diffuse collagen disease: Acute disseminated lupus erythematosus and diffuse scleroderma. JAMA 1942; 119: 331–332.Google Scholar
  4. 4.
    Klemperer P. The concept of collagen diseases. Am J Pathol 1950; 26: 505–519.PubMedGoogle Scholar
  5. 5.
    Banks BM. Is there a common denominator in scleroderma, dermatomyositis, disseminated lupus erythematosus, the Libman-Sack syndrome and polyarteritis nodosa? N Engl J Med 1941; 225: 433–444.Google Scholar
  6. 6.
    Rich AR. Hypersensitivity in disease, with special reference to periarteritis nodosa, rheumatic fever, disseminated lupus erythematosus and rheumatoid arthritis. Harvey Lect 1947; 42: 106–147.Google Scholar
  7. 7.
    Hunninghake GW, Fauci AS. Pulmonary involvement in the collagen vascular diseases. Am Rev Respir Dis 1979; 119: 471–503.PubMedGoogle Scholar
  8. 8.
    Boulware DW, Weissman DN, Doll NJ. Pulmonary manifestations of the rheumatic diseases. Clin Rev Allergy 1985; 3: 249–267.PubMedGoogle Scholar
  9. 9.
    Harmon KR, Leatherman JW. Respiratory manifestations of connective tissue disease. Semin Respir Infect 1988; 3: 258–273.PubMedGoogle Scholar
  10. 10.
    Wiedemann HP, Matthay RA. Pulmonary manifestations of collagen vascular disease. Clin Chest Med 1989; 10: 677–722.PubMedGoogle Scholar
  11. 11.
    Colby TV. Lung pathology. In: Cannon GW, Zimmerman GA, eds. The lung in rheumatic diseases. New York: Marcel Dekker, 1990: 145–178.Google Scholar
  12. 12.
    Wise RA. Pulmonary complications in collagen-vascular disease. In: Lynch JP III, DeRemee RA, eds. Immunologically mediated pulmonary diseases. Philadelphia: JB Lippincott, 1991: 40–88.Google Scholar
  13. 13.
    Eisenberg H. The interstitial lung diseases associated with the collagen-vascular disorders. Clin Chest Med 1982; 3: 565–578.PubMedGoogle Scholar
  14. 14.
    Coleman WP, III, Coleman WP, Derbes VJ, Jolly HW, Jr., Nesbitt LT, Jr. Collagen disease in children: A review of 71 cases. JAMA 1977; 237: 1095–1100.PubMedGoogle Scholar
  15. 15.
    Goldsmith DP. Neonatal rheumatic disorders: views of the pediatrician. Rheum Dis Clin North Am 1989; 15: 287–305.PubMedGoogle Scholar
  16. 16.
    Cannon GW. Pulmonary complications of antirheumatic drug therapy. Semin Arthritis Rheum 1990; 19: 353–364.PubMedGoogle Scholar
  17. 17.
    Walker Smith GJ. The histopathology of pulmonary reactions to drugs. Clin Chest Med 1990; 11: 95–117.Google Scholar
  18. 18.
    Wall CP, Gaensler EA, Carrington CB, Hayes JA. Comparison of transbronchial and open biopsies in chronic infiltrative lung disease. Am Rev Respir Dis 1981; 123: 280–285.PubMedGoogle Scholar
  19. 19.
    Nagata N, Hirano H, Takayama K, Miyagawa Y, Shigematsu N. Step section preparation of transbronchial lung biopsy. Chest 1991; 100: 959–962.PubMedGoogle Scholar
  20. 20.
    Gaensler EA, Carrington CB. Open biopsy for chronic diffuse infiltrative lung disease: clinical, roentgenographic and physiological correlation in 502 patients. Ann Thorac Surg 1980; 30: 411–426.PubMedGoogle Scholar
  21. 21.
    Meduri GU, Stover DE, Greeno RA, Nash T, Zaman MB. Bilateral bronchoalveolar lavage in the diagnosis of opportunistic pulmonary infections. Chest 1991; 100: 1272–1276.PubMedGoogle Scholar
  22. 22.
    Jansen HM, Schutte AJ, van der Giessen M, The TH. Immunoglobulin classes in local immune complexes recovered by bronchoalveolar lavage in collagen vascular diseases. Lung 1984; 162: 287–296.PubMedGoogle Scholar
  23. 23.
    Rossi GA, Bitterman PB, Rennard SI, Ferrans VJ, Crystal RG. Evidence for chronic inflammation as a component of the interstitial lung disease associated with progressive systemic sclerosis. Am Rev Respir Dis 1985; 131: 612–617.PubMedGoogle Scholar
  24. 24.
    Garcia JGN, Wolven RG, Garcia PL, Keogh BA. Assessment of interlobar variation of bronchoalveolar lavage cellular differentials in interstitial lung diseases. Am Rev Respir Dis 1986; 133: 444–449.PubMedGoogle Scholar
  25. 25.
    Chamberlain DW, Braude AC, Rebuck AS. A critical evaluation of bronchoalveolar lavage: criteria for identifying unsatisfactory specimens. Acta Cytol 1987; 31: 599–605.PubMedGoogle Scholar
  26. 26.
    Stoller JK, Rankin JA, Reynolds HY. The impact of bronchoalveolar lavage cell analysis on clinicians’, diagnostic reasoning about interstitial lung disease. Chest 1987; 92: 839–943.PubMedGoogle Scholar
  27. 27.
    Turner-Warwick M, Haslam P. The value of serial bronchoalveolar lavages in assessing the clinical progress of patients with cryptogenic fibrosing alveolitis. Am Rev Respir Dis 1987; 135: 26–34.PubMedGoogle Scholar
  28. 28.
    Reynolds HY. Bronchoalveolar lavage. Am Rev Respir Dis 1987; 135: 250–263.PubMedGoogle Scholar
  29. 29.
    Siemsen JK, Grebe SF, Waxman AD. The use of gallium-67 in pulmonary disorders. Semin Nucl Med 1978; 8: 235–249.PubMedGoogle Scholar
  30. 30.
    Line BR, Fulmer JD, Reynolds HY, et al. Gallium-67 citrate scanning in the staging of idiopathic pulmonary fibrosis: correlation with physiologic and morphologic features and bronchoalveolar lavage. Am Rev Respir Dis 1978; 118: 355–365.PubMedGoogle Scholar
  31. 31.
    Greene NB, Solinger AJ, Baughman RP. Patients with collagen-vascular disease and dyspnea: The value of gallium scanning and bronchoalveolar lavage in predicting response to steroid therapy and clinical outcome. Chest 1987; 91: 698–703.PubMedGoogle Scholar
  32. 32.
    Elstad MR. Lung biopsy, bronchoalveolar lavage, and gallium scanning. In: Cannon GW, Zimmerman GA, eds. The lung in rheumatic diseases. New York: Marcel Dekker, 1990: 117–143.Google Scholar
  33. 33.
    Ellman P, Cudkowicz L. Pulmonary manifestations in the diffuse collagen diseases. Thorax 1954; 9: 46–57.PubMedGoogle Scholar
  34. 34.
    Von Glahn WC, Pappenheimer AM. Specific lesions of peripheral blood vessels in rheumatism. Am J Pathol 1926; 2: 235–250.Google Scholar
  35. 35.
    Massumi RA, Legier JF. Rheumatic pneumonitis. Circulation 1966; 33: 417–425.PubMedGoogle Scholar
  36. 36.
    Gouley BA. The evolution of the parenchymal lung lesions in rheumatic fever and their relationship to mitral stenosis and passive congestion. Am J Med Sci 1938; 196: 1–10.Google Scholar
  37. 37.
    Muirhead EE, Haley AE. Rheumatic pneumonitis: A case of widespread chronic (proliferative) type with acute (exudative) foci. Arch Intern Med 1947; 80: 328–342.Google Scholar
  38. 38.
    Garrod AB. The great practical importance of separating rheumatoid arthritis from gout. Lancet 1982; ii: 1033–1037.Google Scholar
  39. 39.
    Ellman P, Ball RE. “Rheumatoid disease” with joint and pulmonary manifestations. Lancet 1948; ii: 816–820.Google Scholar
  40. 40.
    Petty TL, Wilkins M. The five manifestations of rheumatoid lung. Dis Chest 1966; 49: 75–82.PubMedGoogle Scholar
  41. 41.
    Walker WC, Wright V. Pulmonary lesions and rheumatoid arthritis. Medicine (Baltimore) 1968; 47: 501–502.Google Scholar
  42. 42.
    Scadding JG. The lungs in rheumatoid arthritis. Proc R Soc Med 1969; 62: 227–238.PubMedGoogle Scholar
  43. 43.
    Strimlan CV, Rosenow EC, III, Weiland LH, Brown LR. Lymphocytic interstitial pneumonitis: Review of 13 cases. Ann Intern Med 1978; 88: 616–621.PubMedGoogle Scholar
  44. 44.
    Epler GR, Suider GL, Gaensler EA, Cathcart ES, Fitzgerald MX, Carrington CB. Bronchiolitis and bronchitis in connective tissue disease. JAMA 1979; 242: 528–532.PubMedGoogle Scholar
  45. 45.
    Cervantes-Perez P, Toro-Perez AH, Rodriguez-Jurado P. Pulmonary involvement in rheumatoid arthritis. JAMA 1980; 243: 1715–1719.PubMedGoogle Scholar
  46. 46.
    Herzog CA, Miller RR, Hoidal JR. Bronchiolitis and rheumatoid arthritis. Am Rev Respir Dis 1981; 124: 636–639.PubMedGoogle Scholar
  47. 47.
    Yousem SA, Colby TR, Carrington CB. Lung biopsy in rheumatoid arthritis. 1985; 131: 770–777.Google Scholar
  48. 48.
    Hakala M, Pääkko P, Huhti E, Tarkka M, Sutinen S. Open lung biopsy of patients with rheumatoid arthritis. Clin Rheumatol 1990; 9: 452–460.PubMedGoogle Scholar
  49. 49.
    Turner-Warwick M, Evans RC. Pulmonary manifestations of rheumatoid disease. Clin Rheum Dis 1977; 3: 549–564.Google Scholar
  50. 50.
    MacFarlane JD, Dieppe PA, Rigden BG, Clark TJ. Pulmonary pleural lesions in rheumatoid disease. Br J Dis Chest 1978; 72: 288–300.PubMedGoogle Scholar
  51. 51.
    Popper MS, Bogdonoff ML, Hughes RI. Interstitial rheumatoid lung disease. Chest 1972; 62: 243–249.PubMedGoogle Scholar
  52. 52.
    Frank ST, Weg JG, Harkelroad LE, Fitch RF. Pulmonary dysfunction in rheumatoid disease. Chest 1973; 63: 27–34.PubMedGoogle Scholar
  53. 53.
    Laitinen O, Nissila M, Salorinne Y, Aalto P. Pulmonary involvement in patients with rheumatoid arthritis. Scand J Respir Dis 1975; 56: 297–304.PubMedGoogle Scholar
  54. 54.
    Geddes DM, Webley M, Emerson PA. Airway obstruction in rheumatoid arthritis. Ann Rheum Dis 1979; 38: 222–225.PubMedGoogle Scholar
  55. 55.
    Hill EA, Davies S, Geary M. Frequency dependence of dynamic compliance in patients with rheumatoid arthritis. Thorax 1979; 34: 755–761.Google Scholar
  56. 56.
    Epler GR, McLoud TC, Gaensler EA, Mikus JP, Carrington CB. Normal chest roentgenograms in chronic diffuse infiltrative lung disease. N Engl J Med 1978; 298: 934–939.PubMedGoogle Scholar
  57. 57.
    Patterson CD, Harville WE, Pierce JA. Rheumatoid lung disease. Ann Intern Med 1965; 62: 685–697.PubMedGoogle Scholar
  58. 58.
    Martel W, Abell MR, Mikkelsen WM, Whitehouse WM. Pulmonary and pleural lesions in rheumatoid disease. Radiology 1968; 90: 641–653.PubMedGoogle Scholar
  59. 59.
    Walker WC, Wright V. Diffuse interstitial pulmonary fibrosis and rheumatoid arthritis. Ann Rheum Dis 1969; 28: 252–259.PubMedGoogle Scholar
  60. 60.
    Cruickshank B. Interstitial pneumonia and its consequences in rheumatoid disease. Br J Dis Chest 1959; 53: 226–236.PubMedGoogle Scholar
  61. 61.
    Baggenstoss AH, Rosenberg EF. Visceral lesions associated with chronic infectious (rheumatoid) arthritis. Arch Pathol 1943; 35: 503–516.Google Scholar
  62. 62.
    Walker WC, Wright V. Rheumatoid pleuritis. Ann Rheum Dis 1967; 26: 467–474.PubMedGoogle Scholar
  63. 63.
    Shiel WC, Jr., Prete PE. Pleuropulmonary manifestations of rheumatoid arthritis. Semin Arthritis Rheum 1984; 13: 235–243.PubMedGoogle Scholar
  64. 64.
    Jurik AG, Davidsen D, Graudal H. Prevalence of pulmonary involvement in rheumatoid arthritis and its relationship to some characteristics of the patients: A radiological and clinical study. Scand J Rheumatol 1982; 11: 217–224.PubMedGoogle Scholar
  65. 65.
    Sahn SA, Kaplan RL, Maulitz RM, Good JT. Rheumatoid pleurisy, observations on the development of low pleural fluid pH and glucose level. Arch Intern Med 1980; 140: 1237–1238.PubMedGoogle Scholar
  66. 66.
    Patterson T, Klockars M, Hellstrom PE. Chemical and immunological features of pleural effusion: comparison between rheumatoid arthritis and other diseases. Thorax 1982; 37: 354–361.Google Scholar
  67. 67.
    Faurschou P. Decreased glucose in RA cell-positive pleural effusion, correlation of pleural glucose, lactic dehydrogenase and protein concentration to the presence of RA cells. Eur J Respir Dis 1984; 65: 272–277.PubMedGoogle Scholar
  68. 68.
    Faurschou P, Francis D, Faarup P. Thoracoscopic, histological and clinical findings in nine cases of rheumatoid pleural effusion. Thorax 1985; 40: 371–375.PubMedGoogle Scholar
  69. 69.
    Champion GD, Robertson MR, Robinson RG. Rhematoid pleurisy and pericarditis. Ann Rheum Dis 1968; 27: 521–530.PubMedGoogle Scholar
  70. 70.
    Aru A, Engel U, Francis D. Characteristic and specific histological findings in rheumatoid pleurisy. Acta Pathol Microbiol Immunol Scand Sect A (Suppl) 1986; 94: 57–62.Google Scholar
  71. 71.
    Wells WC. On rheumatism of the heart. Trans Soc Improv Med Chirug Knowl 1812; 3: 373–424.Google Scholar
  72. 72.
    Osier W, McCrae T, eds. Modern medicine: Its theory & practice. New York: Lea and Febiger 1909: 501–509, 534–536.Google Scholar
  73. 73.
    Duthie JJR, Brown PE, Truelove LH, et al. Course and prognosis in rheumatoid arthritis: A further report. Ann Rheum Dis 1964; 23: 193–204.PubMedGoogle Scholar
  74. 74.
    Gordon DA, Stein JL, Broder I. The extra-articular features of rheumatoid arthritis: A systematic analysis of 127 cases. Am J Med 1973; 54: 445–452.PubMedGoogle Scholar
  75. 75.
    Benedek TG. Subcutaneous nodules and the differentiation of rheumatoid arthritis from rheumatic fever. Semin Arthritis Rheum 1984; 13: 305–321.PubMedGoogle Scholar
  76. 76.
    Eraut D, Evans J, Caplan M. Pulmonary necrobiotic nodules without rheumatoid arthritis. Br J Dis Chest 1978; 72: 301–306.PubMedGoogle Scholar
  77. 77.
    Hull S, Mathews JA. Pulmonary necrobiotic nodules as a presenting feature of rheumatoid arthritis. Ann Rheum Dis 1982; 41: 21–24.PubMedGoogle Scholar
  78. 78.
    Nusslein HG, Rodl W, Giedel J, Missmahl M, Kalden JR. Multiple peripheral pulmonary nodules preceding rheumatoid arthritis. Rheumatol Int 1987; 7: 89–91.PubMedGoogle Scholar
  79. 79.
    Baumer HM, Van Belle CJ. Pulmonary nodules in rheumatoid arthritis. Respiration 1972; 29: 556–563.Google Scholar
  80. 80.
    Kaye B, Kaye R, Bobrove A. Rheumatoid nodules: Review of the spectrum of associated conditions and proposal of a new classification, with a report of four seronegative cases. Am J Med 1984; 76: 279–292.PubMedGoogle Scholar
  81. 81.
    Burrows FG. Pulmonary nodules in rheumatoid disease: A report of two cases. Br J Radio! 1967; 40: 256–261.Google Scholar
  82. 82.
    Johnson TS, White P, Weiss ST, et al. Endobronchial necrobiotic nodule antedating rheumatoid arthritis. Chest 1982; 82: 199–200.PubMedGoogle Scholar
  83. 83.
    Ellman P, Cudkowicz L, Elwood JS. Widespread serous membrane involvements by rheumatoid nodules. J Clin Pathol 1954; 7: 239–244.PubMedGoogle Scholar
  84. 84.
    Walters MN, Ojeda VJ. Pleuropulmonary necrobiotic rheumatoid nodules: A review and clinicopathologic study of six patients. Med J Aust 1986; 144: 648–651.PubMedGoogle Scholar
  85. 85.
    Ziff M. The rheumatoid nodule. Arthritis Rheum 1990; 33: 761–767.PubMedGoogle Scholar
  86. 86.
    Crisp AJ, Armstrong RD, Graham R, Dussek JE. Rheumatoid lung, pneumothorax and eosinophilia. Ann Rheum Dis 1982; 41: 137–140.PubMedGoogle Scholar
  87. 87.
    Yue CC, Park CH, Kushner I. Apical fibrocavitary lesions of the lung in rheumatoid arthritis: Report of two cases and review of the literature. Am J Med 1986; 81: 741–746.PubMedGoogle Scholar
  88. 88.
    McConnochie K, O’Sullivan M, Khalil JF, Pritchard MH, Gibbs AR. Aspergillus colonization of pulmonary rheumatoid nodule. Respir Med 1989; 83: 157–160.PubMedGoogle Scholar
  89. 89.
    Pillemer SR, Webb D, Yocum DE. Legionnaire’s disease in a patient with rheumatoid arthritis treated with cyclosporin. J Rheumatol 1989; 16: 117–120.PubMedGoogle Scholar
  90. 90.
    Watkin SW, Bucknall RC, Nisar M, Agnew RA. Atypical mycobacterial infection of the lung in rheumatoid arthritis. Ann Rheum Dis 1989; 48: 336–338.PubMedGoogle Scholar
  91. 91.
    Caplan A. Certain radiological appearances in the chest of coal miners suffering from rheumatoid arthritis. Thorax 1953; 8: 29–37.PubMedGoogle Scholar
  92. 92.
    Caplan A, Payne RB, Withey JL. A broader concept of Caplan’s syndrome related to rheumatoid factors. Thorax 1962; 17: 205–212.PubMedGoogle Scholar
  93. 93.
    Benedik TG. Rheumatoid pneumoconiosis. Am J Med 1973; 55: 515–524.Google Scholar
  94. 94.
    Crystal RG, Rennard S. Pulmonary connective tissue and environmental lung disease. Chest 1981; 80 (1): 33S - 38S.Google Scholar
  95. 95.
    Sluis-Cremer GK. Respiratory manifestation of rheumatoid arthritis. S Afr Med J 1970; 44: 843–846.PubMedGoogle Scholar
  96. 96.
    Wagner JC. Pulmonary fibrosis and mineral dusts. Ann Rheum Dis 1977; 36 (Suppl): 42–46.Google Scholar
  97. 97.
    Roschmann RA, Rothenberg RJ. Pulmonary fibrosis in rheumatoid arthritis: A review of clinical features and therapy. Semin Arthritis Rheum 1987; 16: 174–185.PubMedGoogle Scholar
  98. 98.
    Wagener JS, Taussig LM, DeBenedetti C, et al. Pulmonary function in juvenile rheumatoid arthritis. J Pediatr 1981; 99: 108–110.PubMedGoogle Scholar
  99. 99.
    DeHoratius RJ, Abruzzo JL, Williams RC. Immunofluorescent and immunologic studies of rheumatoid lung. Arch Intern Med 1972; 129: 441–446.PubMedGoogle Scholar
  100. 100.
    Geddes DM, Corrin B, Brewerton DA, Daires RJ, Turner-Warwick M. Progressive airway obliteration in adults and its association with rheumatoid disease. Q J Med 1977; 46: 427–444.PubMedGoogle Scholar
  101. 101.
    Penny WJ, Knight RK, Rees AM, Thomas AL, Smith AP. Obliterative bronchiolitis in rheumatoid arthritis. Ann Rheum Dis 1982; 41: 469–472.PubMedGoogle Scholar
  102. 102.
    Garcia JGN, James HL, Zinkgraf S, Perlman MB, Keogh BA. Lower respiratory tract abnormalities in rheumatoid interstitial lung disease: Potential role of neutrophils in lung injury. Am Rev Respir Dis 1987; 136: 811–817.PubMedGoogle Scholar
  103. 103.
    Scott DGI, Bacon PA, Tribe CR. Systemic rheumatoid vasculitis: A clinical and laboratory study of 50 cases. Medicine (Baltimore) 1981; 60: 288–297.Google Scholar
  104. 104.
    Vollertsen RS, Conn RL, Ballard DJ, Ilstrup DM, Kaz-mar RE, Silverfield JC. Rheumatoid vasculitis: survival and associated risk factors. Medicine (Baltimore) 1986; 65: 365–375.Google Scholar
  105. 105.
    Case records of the Massachusetts General Hospital: Case 3–1982. N Engl J Med 1982; 306: 157–164.Google Scholar
  106. 106.
    Lakhanpal S, Conn DL, Lie JT. Clinical and prognostic significance of vasculitis as an early manifestation of connective tissue syndromes. Ann Intern Med 1984; 101: 743–748.PubMedGoogle Scholar
  107. 107.
    Theofilopoulos AN, Burtonboy G, LoSpalluto JJ, et al. IgM rheumatoid factor and low molecular weight IgM, an association with vasculitis. Arthritis Rheum 1974; 17: 272–284.PubMedGoogle Scholar
  108. 108.
    Veys EM, Gabriel PA, Coigne E, et al. Rheumatoid factor and serum IgG, IgM and IgA levels in rheumatoid arthritis and vasculitis. Scand J Rheumatol 1976; 5: 1–6.PubMedGoogle Scholar
  109. 109.
    Kay JM, Banik S. Unexplained pulmonary hypertension with pulmonary arteritis in rheumatoid disease. Br J Dis Chest 1977; 71: 53–59.PubMedGoogle Scholar
  110. 110.
    Baydur A, Mongan ES, Slager UT. Acute respiratory failure and pulmonary arteritis without parenchymal involvement: demonstration in a patient with rheumatoid arthritis. Chest 1979; 75: 518–520.PubMedGoogle Scholar
  111. 111.
    Gardner DL, Duthie JJ, McLeod J, Allan WS. Pulmonary hypertension in rheumatoid arthritis: Report of a case with intimal sclerosis of the pulmonary and digital arteries. Scot Med J 1957; 2: 183–186.PubMedGoogle Scholar
  112. 112.
    Onodera S, Hill JR. Pulmonary hypertension: Report of a case in association with rheumatoid arthritis. Ohio State Med J 1965; 61: 141–144.PubMedGoogle Scholar
  113. 113.
    Armstrong JG, Steel RH. Localized pulmonary arteritis in rheumatoid disease. Thorax 1982; 37: 313–314.PubMedGoogle Scholar
  114. 114.
    Morikawa J, Kitamura K, Habuchi Y, Tsujimura Y, Minamikawa T, Takamatsu T. Pulmonary hypertension in a patient with rheumatoid arthritis. Chest 1988; 93: 876–878.PubMedGoogle Scholar
  115. 115.
    Jordan JD, Snyder CH. Rheumatoid disease of the lung and cor pulmonale: Observations in a child. Am J Dis Child 1964; 108: 174–180.Google Scholar
  116. 116.
    Romicka A, Maldyk E. Pulmonary lesions in the course of rheumatoid arthritis in children. Pol Med Sci Hist Bull 1975; 18: 263–268.Google Scholar
  117. 117.
    Yousefzadeh DK, Fishman PA. The triad of pneumonitis, pleuritic, and pericarditis in juvenile rheumatoid arthritis. Pediatr Radiol 1979; 8: 147–150.PubMedGoogle Scholar
  118. 118.
    Athreya BH, Doughty RA, Bookspan M, et al. Pulmonary manifestations of juvenile rheumatoid arthritis. Clin Chest Med 1980; 1: 361–374.PubMedGoogle Scholar
  119. 119.
    Kaposi M. Idiopathisches multiples pigmentsarkom der haut. Arch Dermatol Syphilol 1872; 4: 265–273.Google Scholar
  120. 120.
    Osler W. On the visceral manifestations of the erythema group of skin diseases. Am J Med Sci 1904; 127: 1–23.Google Scholar
  121. 121.
    Rakov HL, Taylor JS. Acute disseminated lupus erythematosus without cutaneous manifestations and with heretofore undescribed pulmonary lesions. Arch Intern Med 1942; 70: 88–100.Google Scholar
  122. 122.
    Israel HL. The pulmonary manifestations of disseminated lupus erythematosus. Am J Med Sci 1953; 226: 387–392.PubMedGoogle Scholar
  123. 123.
    Purnell DC, Baggenstoss AH, Olsen AM. Pulmonary lesions in disseminated lupus erythematosus. Ann Intern Med 1955; 42: 619–628.PubMedGoogle Scholar
  124. 124.
    Aitchison JD, Williams AW. Pulmonary changes in disseminated lupus erythematosus. Ann Rheum Dis 1956; 15: 26–32.PubMedGoogle Scholar
  125. 125.
    Myrhe JR. Pleuropulmonary manifestations in lupus erythematosus disseminatus. Acta Med Scand 1959; 165: 55–60.Google Scholar
  126. 126.
    Alarcón-Segovia D, Alarcón DG. Pleuro-pulmonary manifestations of systemic lupus erythematosus. Dis Chest 1961; 39: 7–17.PubMedGoogle Scholar
  127. 127.
    Sullivan MA, Miller DK. Pulmonary manifestations in collagen disease. Arch Intern Med 1962; 110: 769–781.PubMedGoogle Scholar
  128. 128.
    Gross M, Esterly JR, Earle RH. Pulmonary alterations in systemic lupus erythematosus. Am Rev Respir Dis 1972; 105: 572–577.PubMedGoogle Scholar
  129. 129.
    Olsen EGJ, Lever JV. Pulmonary changes in systemic lupus erythematosus. Br J Dis Chest 1972; 66: 71–77.PubMedGoogle Scholar
  130. 130.
    Eisenberg H, Dubois EL, Sherwin RP, Balchum OJ. Diffuse interstitial lung disease in systemic lupus erythematosus. Ann Intern Med 1973; 79: 37–45.PubMedGoogle Scholar
  131. 131.
    Matthay RA, Schwarz MI, Petty TL, et al. Pulmonary manifestations of systemic lupus erythematosus: Review of 12 cases of acute lupus pneumonitis. Medicine (Baltimore) 1975; 54: 397–409.Google Scholar
  132. 132.
    Holgate ST, Glass DN, Haslam P, Maini RN, Turner-Warwick M. Respiratory involvement in systemic lupus erythematosus. A clinical and immunological study. Clin Exp Immunol 1976; 24: 385–395.PubMedGoogle Scholar
  133. 133.
    Fayemi AO. Pulmonary vascular disease in systemic lupus erythematosus. Am J Clin Pathol 1976; 65: 284–290.PubMedGoogle Scholar
  134. 134.
    Pertschuk LP, Moccia LF, Rosen Y, et al. Acute pulmonary complications in systemic lupus erythematosus. Immunofluorescence and light microscopic study. Am J Clin Pathol 1977; 68: 553–557.PubMedGoogle Scholar
  135. 135.
    Eagen JW, Memoli VA, Roberts JL, Matthew GR, Schwartz MM, Lewis EJ. Pulmonary hemorrhage in systemic lupus erythematosus. Medicine (Baltimore) 1978; 57: 545–560.Google Scholar
  136. 136.
    Yum MN, Ziegler JR, Walker PD, Ridolfo AS, Brashear RE. Pseudolymphoma of the lung in a patient with systemic lupus erythematosus. Am J Med 1979; 66: 172–176.PubMedGoogle Scholar
  137. 137.
    Nair SS, Askari AD, Pepilka CG, Kleinerman JF. Pulmonary hypertension and systemic lupus erythematosus. Arch Intern Med 1980; 140: 109–111.PubMedGoogle Scholar
  138. 138.
    Benisch B, Peison B. The association of lymphocytic interstitial pneumonia and systemic lupus erythematosus. Mt Sinai J Med 1979; 46: 398–401.PubMedGoogle Scholar
  139. 139.
    Silberstein SL, Barland P, Grayzel AI, Koerner SK. Pulmonary dysfunction in systemic lupus erythematosus: Prevalence classification and correlation with other organ involvement. J Rheumatol 1980; 7: 187–195.PubMedGoogle Scholar
  140. 140.
    Haupt HM, Moore GW, Hutchins GM. The lung in systemic lupus erythematosus: Analysis of the pathologic changes in 120 patients. Am J Med 1981; 71: 791–798.PubMedGoogle Scholar
  141. 141.
    Quismorio FP, Jr., Sharma O, Koss M, et al. Immunopathologic and clinical studies in pulmonary hypertension associated with systemic lupus erythematosus. Semin Arthritis Rheum 1984; 13: 349–359.PubMedGoogle Scholar
  142. 142.
    Pines A, Kaplinsky N, Olchovsky D, Rozenman J, Frankl O. Pleuro-pulmonary manifestations of systemic lupus erythematosus: clinical features of its subgroups. Chest 1985; 88: 129–135.PubMedGoogle Scholar
  143. 143.
    Miller LR, Greenberg SD, McLarty JW. Lupus lung. Chest 1985; 88: 265–269.Google Scholar
  144. 144.
    Segal AM, Calabrese LH, Ahmad M, Tubbs RR, White CS. The pulmonary manifestations of systemic lupus erythematosus. Semin Arthritis Rheum 1985; 14: 202–224.PubMedGoogle Scholar
  145. 145.
    Quismorio FP Jr. Clinical and pathologic features of lung involvement in systemic lupus erythematosus. Semin Respir Med 1988; 9: 297–304.Google Scholar
  146. 146.
    Weinrib L, Sharma OP, Quismorio FP. A long-term study of interstitial lung disease in systemic lupus erythematosus. Semin Arthritis Rheum 1990; 20: 48–56.PubMedGoogle Scholar
  147. 147.
    Dubois EL, Tuffanelli DL. Clinical manifestations of systemic lupus erythematosus: Computer analysis of 520 cases. JA MA 1964; 190: 104–111.Google Scholar
  148. 148.
    Harvey AM, Shulman LE, Tumulty PA, Conley CL, Schoenrich EH. Systemic lupus erythematosus: Review of the literature and clinical analysis of 138 cases. Medicine (Baltimore) 1954: 33: 291–437.Google Scholar
  149. 149.
    Nozawa Y. Histopathological findings of the lung in collagen disease-especially on their differential diagnosis. Acta Pathol Jpn 1972; 22: 843–858.PubMedGoogle Scholar
  150. 150.
    Kinney WW, Angellillo VA. Bronchiolitis in systemic lupus erythematosus. Chest 1982; 82: 646–649.PubMedGoogle Scholar
  151. 151.
    Mintz G, Galindo LF, Fernandez DJ, et al. Acute massive pulmonary hemorrhage in systemic lupus erythematosus. J Rheumatol 1976; 5: 39–50.Google Scholar
  152. 152.
    Perez HD, Kramer H. Pulmonary hypertension in systemic lupus erythematosus: Report of four cases and review of the literature. Semin Arthritis Rheum 1981; 11: 177–181.PubMedGoogle Scholar
  153. 153.
    Abud-Mendoza C, Diaz-Jouanen E, Alarcon-Segovia D. Fatal pulmonary hemorrhage in systemic lupus erythematosus: Occurrence without hemoptysis. J Rheumatol 1985; 12: 558–561.PubMedGoogle Scholar
  154. 154.
    Myers JL, Katzenstein AL. Microangiitis in lupus-induced pulmonary hemorrhage. Am J Clin Pathol 1986; 85: 552–556.PubMedGoogle Scholar
  155. 155.
    Asherson RA, Hackett D, Gharavi AE, Harris EN, Kennedy HG, Hughes GRV. Pulmonary hypertension in systemic lupus erythematosus: A report of three cases. J Rheumatot 1986; 13: 416 420.Google Scholar
  156. 156.
    Kasukawa R, Nishimaki T, Takagi T, Miyawaki S, Yokohari R, Tsunematsu T. Pulmonary hypertension in connective tissue disease: Clinical analysis of sixty patients in multi-institutional study. Clin Rheumatol 1990; 9: 56–62.PubMedGoogle Scholar
  157. 157.
    Eagen JW, Roberts JL, Schartz MM, Lewis EJ. The composition of pulmonary immune deposits in systemic lupus erythematosus. Clin Immunol Immunopathol 1979; 12: 204–219.PubMedGoogle Scholar
  158. 158.
    Churg A, Franklin W, Chan KW, Kopp E, Carrington CB. Pulmonary hemorrhage and immune-complex deposition in the lung. Arch Pathol Lab Med 1980; 104: 388–391.PubMedGoogle Scholar
  159. 159.
    Fraire AE, Smith MN, Greenberg SD, Weg JG, Sharp JT. Tubular structures in pulmonary endothelial cells in systemic lupus erythematosus. Am J Clin Pathol 1971; 56: 244–248.PubMedGoogle Scholar
  160. 160.
    Lyon MG, Bewtra C, Kenik JG, Hurley JA. Tubuloreticular inclusions in systemic lupus pneumonitis. Arch Pathol Lab Med 1984; 108: 599–600.PubMedGoogle Scholar
  161. 161.
    Hoffbrand BI, Beck ER. Unexplained dyspnea and shrinking lungs in systemic lupus erythematosus. Br Med J 1963; 1: 1273–1277.Google Scholar
  162. 162.
    Chick TW, Dettoratius RJ, Skipper BE, Messuer RP. Pulmonary dysfunction in systemic lupus erythematosus without pulmonary symptoms. J Rheumatol 1976; 3: 262–268.PubMedGoogle Scholar
  163. 163.
    Rubin LA, Urowitz MB. Shrinking lung syndrome in SLE: A clinical pathological study. J Rheumatol 1983; 10: 973–976.PubMedGoogle Scholar
  164. 164.
    Martens J, Demedts M, Vanmeenen MT, Degulker J. Respiratory muscle dysfunction in systemic lupus erythematosus. Chest 1984; 84: 170–175.Google Scholar
  165. 165.
    Jacobelli S, Moreno R, Massardo L, Rivero S, Lisboa C. Inspiratory muscle dysfunction and unexplained dyspnea in systemic lupus erythematosus. Arthritis Rheum 1985; 28: 781–788.PubMedGoogle Scholar
  166. 166.
    Eichacker PQ, Pinsker K, Epstein A, Schiffenbauer J, Grayzel A. Serial pulmonary function testing in patients with systemic lupus erythematosus. Chest 1988; 94: 129–132.PubMedGoogle Scholar
  167. 167.
    Sackner MA. The visceral manifestations of scleroderma. Arthritis Rheum 1962; 5: 184–194.PubMedGoogle Scholar
  168. 168.
    Getzowa S. Cystic and compact pulmonary sclerosis in progressive scleroderma. Arch Pathol 1945; 40: 99–106.Google Scholar
  169. 169.
    Naeye RL. Pulmonary vascular lesions in systemic sclerosis. Dis Chest 1963; 44: 374–380.PubMedGoogle Scholar
  170. 170.
    Wilson RJ, Rodnan GP, Robin ED. An early pulmonary physiologic abnormality in progressive systemic sclerosis (diffuse scleroderma). Am J Med 1964; 36: 361–369.PubMedGoogle Scholar
  171. 171.
    Weaver AL, Divertie MB, Titus JL. Pulmonary scleroderma. Dis Chest 1968; 54: 4–12.Google Scholar
  172. 172.
    D’Angelo WA, Fries JF, Masi AT, Shulman LE. Pathologic observations in systemic sclerosis (scleroderma): A study of fity-eight autopsy cases and fifty-eight matched controls. Am J Med 1969; 46: 428–440.PubMedGoogle Scholar
  173. 173.
    Colp CR, Riker J, Williams MH. Serial changes in scleroderma and idiopathic interstitial lung disease. Arch Intern Med 1973; 132: 506–515.PubMedGoogle Scholar
  174. 174.
    Guttadauria M, Ellman H, Emmanual G, et al. Pulmonary function in scleroderma. Arthritis Rheum 1977; 20: 1071–1079.PubMedGoogle Scholar
  175. 175.
    Salerni R, Rodnan GP, Leon DF, Shaver JA. Pulmonary hypertension in the CREST syndrome variant of progressive systemic sclerosis (scleroderma). Ann Intern Med 1977; 86: 394–399.PubMedGoogle Scholar
  176. 176.
    Kallenbach J, Prinsloo I, Zwi S. Progressive systemic sclerosis complicated by diffuse pulmonary hemorrhage. Thorax 1977; 32: 767–770.PubMedGoogle Scholar
  177. 177.
    Young RH, Mark GJ. Pulmonary vascular changes in scleroderma. Am J Med 1978; 64: 998–1004.PubMedGoogle Scholar
  178. 178.
    Schneider PD, Wise RA, Hochberg MC, Wigley FM. Serial pulmonary function in systemic sclerosis. Am J Med 1982; 73: 385–394.PubMedGoogle Scholar
  179. 179.
    Ungerer RG, Tashkin DP, Furst D, et al. Prevalence and clinical correlates of pulmonary arterial hypertension in progressive systemic sclerosis. Am J Med 1983; 75: 65–74.PubMedGoogle Scholar
  180. 180.
    Konig G, Luderschmidt C, Hammer C, Adelmann-Grill BC, Braun-Falco O, Fruhmann G. Lung involvement in scleroderma. Chest 1984; 85: 318–324.PubMedGoogle Scholar
  181. 181.
    Steen VD, Owens GR, Fino GJ, Rodnan GP, Medsger TA, Jr. Pulmonary involvement in systemic sclerosis (scleroderma). Arthritis Rheum 1985; 28: 759–767.PubMedGoogle Scholar
  182. 182.
    Stupi AM, Steen VD, Owens GR, Barnes EL, Rodnan GP, Medsger TA, Jr. Pulmonary hypertension in the CREST syndrome variant of systemic sclerosis. Arthritis Rheum 1986; 29: 515–524.PubMedGoogle Scholar
  183. 183.
    Owens GR, Follanbee WP. Cardiopulmonary manifestations of systemic sclerosis. Chest 1987; 91: 118–127.PubMedGoogle Scholar
  184. 184.
    Lie JT. Pulmonary hypertension in the CREST syndrome variant of systemic sclerosis (scleroderma). Angiology 1989; 40: 764–767.PubMedGoogle Scholar
  185. 185.
    Silver RM, Miller KS. Lung involvement in systemic sclerosis. Rheum Dis Clin North Am 1990; 16: 199–216.PubMedGoogle Scholar
  186. 186.
    Altman RD, Medsger TA, Jr., Bloch DA, Michel BA. Predictors of survival in systemic sclerosis (scleroderma). Arthritis Rheum 1991; 34: 403–413.PubMedGoogle Scholar
  187. 187.
    Day WDF. Case of scleroderma with the autopsy and remarks. Am J Med Sci 1870; 59: 350–359.Google Scholar
  188. 188.
    Taormina VJ, Miller WT, Gefter WB, Epstein DM. Progressive systemic sclerosis subgroups: Variable pulmonary features. AJR 1981; 137: 277–285.PubMedGoogle Scholar
  189. 189.
    Bettmann MA, Kantrowitz F. Rapid onset of lung involvement in progressive systemic sclerosis. Chest 1979; 75: 509–510.PubMedGoogle Scholar
  190. 190.
    Bookman AAM, Urowitz MB, Mitchell RI. Alveolar cell carcinoma in progressive systemic sclerosis. J RheumatolGoogle Scholar
  191. 1974;.
    :466–472.Google Scholar
  192. 191.
    Talbott JH, Barrocas M. Progressive systemic sclerosis (PSS) and malignancy, pulmonary and non-pulmonary. Medicine (Baltimore) 1979; 58: 182–207.Google Scholar
  193. 192.
    Talbott JH, Barrocas M. Carcinoma of the lung in progressive systemic sclerosis: A tabular review of the literature and a detailed report of roentgenographic changes in two cases. Semin Arthritis Rheum 1980; 9: 191–217.PubMedGoogle Scholar
  194. 193.
    Peters-Golden M, Wise RA, Hochberg M, Stevens MB, Wigley FM. Incidence of lung cancer in systemic sclerosis. J Rheumatol 1985; 12: 1136–1139.PubMedGoogle Scholar
  195. 194.
    Roumm AD, Medsger TA, Jr. Cancer and systemic sclerosis: An epidemiologic study. Arthritis Rheum 1985; 28: 1336–1340.PubMedGoogle Scholar
  196. 195.
    Goodfield MJ, Millard LG. Systemic sclerosis in association with multiple primary pulmonary malignancy: A marker of internal malignancy? Postgrad Med J 1988; 64: 866–868.Google Scholar
  197. 196.
    Enzenauer RJ, McKoy J, Riel M. Rapidly progressive systemic sclerosis associated with carcinoma of the lung. Mil Med 1989;154:574–577.Google Scholar
  198. 197.
    Edwards WG, Jr., Dines DE. Recurrent spontaneous pneumothorax in diffuse scleroderma: Report of a case. Dis Chest 1966; 49: 96–98.PubMedGoogle Scholar
  199. 198.
    Kim JH, Follett JV, Rice JR, Hampson NB. Endobronchial telangiectasis and hemoptysis in scleroderma. Am J Med 1988; 84: 173–174.PubMedGoogle Scholar
  200. 199.
    Russell DC, Maloney A, Muir AL. Progressive generalized scleroderma: Respiratory failure from primary chest wall involvement. Thorax 1981; 36: 219–220.PubMedGoogle Scholar
  201. 200.
    Chausow AM, Kane T, Levinson D, Szidon JP. Reversible hypercapnic respiratory insufficiency in scleroderma caused by respiratory muscle weakness. Am Rev Respir Dis 1984; 130: 143–144.Google Scholar
  202. 201.
    Trell E, Lindström C. Pulmonary hypertension in systemic sclerosis. Ann Rheum Dis 1971; 30: 390–400.PubMedGoogle Scholar
  203. 202.
    Steckel RJ, Bein ME, Kelly PM. Pulmonary arterial hypertension in progressive systemic sclerosis. AJR 1975; 124: 461–465.Google Scholar
  204. 203.
    Kahaleh MB, Sherer GK, LeRoy EC. Endothelial injury in scleroderma. J Exp Med 1979; 149: 1326–1335.PubMedGoogle Scholar
  205. 204.
    Kahaleh MB, LeRoy EC. Endothelial injury in scleroderma. A protease mechanism. J Lab Clin Med 1983; 101: 553–560.PubMedGoogle Scholar
  206. 205.
    Naslund M, Pearson T, Ritter J. A documented episode of pulmonary vasoconstriction in systemic sclerosis. Johns Hopkins Med J 1981; 148: 78–80.PubMedGoogle Scholar
  207. 206.
    Furst DE, Davis JA, Clements PJ, Sawtantra KC, Argyrios NT, Chia D. Abnormalities of pulmonary vascular dynamics and inflammation in early progressive systemic sclerosis. Arthritis Rheum 1981; 24: 1403–1408.PubMedGoogle Scholar
  208. 207.
    Fahey P, Utell M, Condemi J, Breen R, Hyde R. Raynaud’s phenomenon of the lung. Am J Med 1984; 76: 263–269.PubMedGoogle Scholar
  209. 208.
    Shuck JW, Oetgen WJ, Tesar JT. Pulmonary vascular response during Raynaud’s phenomenon in progressive systemic sclerosis. Am J Med 1985; 78: 221–227.PubMedGoogle Scholar
  210. 209.
    Sfikakis PP, Kyriakidis MK, Vergos CG, et al. Cardiopulmonary hemodynamics in systemic sclerosis and response to nifedipine and captopril. Am J Med 1991; 90: 541–546.PubMedGoogle Scholar
  211. 210.
    Thurm CA, Wigley FM, Dole WP, Wise RA. Failure of vasodilator infusion to alter pulmonary diffusing capacity in systemic sclerosis. Am J Med 1991; 90: 542–552.Google Scholar
  212. 211.
    Bohan A, Peters JB. Polymyositis and dermatomyositis. N Engl J Med 1975;292: 344–347, 403–467.Google Scholar
  213. 212.
    Medsger TA, Jr., Dawson WN, Masi AT. The epidemiology of polymyositis. Am J Med 1970; 48: 715–723.PubMedGoogle Scholar
  214. 213.
    Oddis CV, Conte CB, Steen VD, Medsger TA, Jr. Incidence of polymyositis-dermatomyositis: A 20-year study of hospital diagnosed cases in Allegheny County, PA, 1963–1982. J Rheumatol 1990; 17: 1329–1334.PubMedGoogle Scholar
  215. 214.
    Mills ES, Matthews WH. Interstitial pneumonitis in dermatomyositis. JAMA 1956; 160: 1467–1470.Google Scholar
  216. 215.
    Frazier AR, Miller RD. Interstitial pneumonitis in association with polymyositis and dermatomyositis. Chest 1974; 65: 403–407.PubMedGoogle Scholar
  217. 216.
    Salmeron G, Greenberg SD, Lidsky MD. Polymyositis and diffuse interstitial lung disease: A review of the pulmonary histopathologic findings. Arch Intern Med 1981; 141: 1005–1010.PubMedGoogle Scholar
  218. 217.
    Bohan A, Peter JB, Bowman RL, Pearson CM. A computer-assisted analysis of 153 patients with polymyositis and dermatomyositis. Medicine (Baltimore) 1977; 56: 255–286.Google Scholar
  219. 218.
    Songcharoen S, Raju SF, Pennebaker JB. Interstitial lung disease in polymyositis and dermatomyositis. J Rheumatol 1980; 7: 353–360.PubMedGoogle Scholar
  220. 219.
    Dickey BF, Myers AR. Pulmonary disease in polymyositis/dermatomyositis. Semin Arthritis Rheum 1984; 60–76.Google Scholar
  221. 220.
    Takizawa H, Shiga J, Moroi Y, Miyachi S, Nishiwaki M, Miyamoto T. Interstitial lung disease in dermatomyositis: Clinicopathological study. J Rheumatol 1987; 14: 102–107.PubMedGoogle Scholar
  222. 221.
    Hepper NGG, Ferguson RH, Howard FM, Jr. Three types of pulmonary involvement in polymyositis. Med Clin North Am 1964; 48: 1031–1042.PubMedGoogle Scholar
  223. 222.
    Schwarz MI, Matthay RA, Sahn SA, Stanford RE, Marmorstein BL, Scheinhorn DJ. Interstitial lung disease in polymyositis and dermatomyositis: Analysis of six cases and review of the literature. Medicine (Baltimore) 1976; 55: 89–104.Google Scholar
  224. 223.
    Olsen GN, Swenson EVI. Polymyositis and interstitial lung disease. Am Rev Respir Dis 1972; 105: 611–617.PubMedGoogle Scholar
  225. 224.
    Duncan PE, Griffin JP, Garcia A, Kaplan SB. Fibrosing alveolitis in polymyositis: A review of histologically confirmed cases. Am J Med 1974; 57: 621–626.PubMedGoogle Scholar
  226. 225.
    Lakhanpal S, Lie JT, Conn DL, Martin WJ, II. Pulmonary disease in polymyositis/dermatomyositis: A clinico-pathological analysis of 65 autopsy cases. Ann Rheum Dis 1987; 46: 23–29.PubMedGoogle Scholar
  227. 226.
    Tazelaar HD, Viggiano RW, Pickersgill J, Colby TV. Interstitial lung disease in polymyositis and dermatomyositis: Clinical features and prognosis as correlated with histologic findings. Am Rev Respir Dis 1990; 141: 727–733.PubMedGoogle Scholar
  228. 227.
    Caldwell IW, Aitchison JD. Pulmonary hypertension in dermatomyositis. Br Heart J 1956; 18: 273–276.PubMedGoogle Scholar
  229. 228.
    Bunch TW, Tancredi RG, Lie JT. Pulmonary hypertension in polymyositis. Chest 1981; 79: 105–107.PubMedGoogle Scholar
  230. 229.
    Braun NM, Arora NS, Rochster DF. Respiratory muscle and pulmonary function in polymyositis and other proximal myopathies. Thorax 1983; 38: 616–623.PubMedGoogle Scholar
  231. 230.
    Arsura EL, Greenberg AS. Adverse impact of interstitial pulmonary fibrosis on prognosis in polymyositis and dermatomyositis. Semin Arthritis Rheum 1988; 18: 29–37.PubMedGoogle Scholar
  232. 231.
    Cervera R, Khamashta MA, Hughes GRV. `Overlap’ syndromes. Ann Rheum Dis 1990; 49: 947–948.PubMedGoogle Scholar
  233. 232.
    Sharp GE, Irving W, Tan E, Gould G, Holman H. Mixed connective tissue disease: An apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med 1972; 52: 148–159.PubMedGoogle Scholar
  234. 233.
    Alarcon-Segovia D. Symptomatic Sjögren syndrome in mixed connective tissue disease. J Rheumatol 1976; 3: 191–195.PubMedGoogle Scholar
  235. 234.
    Sullivan WD, Hurst DJ, Harmon VE, et al. A prospective evaluation emphasizing pulmonary involvement in patients with mixed connective tissue disease. Medicine (Baltimore) 1984; 63: 92–107.Google Scholar
  236. 235.
    Derderian SS, Tellix CJ, Abbrecht PH, Welton RC, Rajagopal KR. Pulmonary involvement in mixed connective tissue disease. Chest 1985; 88: 45–48.PubMedGoogle Scholar
  237. 236.
    Prakash UBS, Luthra HS, Divertil MB. Intrathoracic manifestations in mixed connective tissue disease. Mayo Clin Proc 1985; 60: 813–821.PubMedGoogle Scholar
  238. 237.
    Prakash UBS. Pulmonary manifestations in mixed connective tissue disease. Semin Respir Med 1988; 9: 318–324.Google Scholar
  239. 238.
    Wiener-Kronish JP, Solinger AM, Warnock ML, Churg AM, Ordonez N, Golden JA. Severe pulmonary involvement in mixed connective tissue disease. Am Rev Respir Dis 1981; 124: 499–503.PubMedGoogle Scholar
  240. 239.
    Meda N, Mimura K, Maeda H, et al. Mixed connective tissue disease with fatal pulmonary hypertension and a review of literature. Virchows Arch A Pathol Anat Histol 1984; 404: 335–340.Google Scholar
  241. 240.
    Hosoda Y, Suzuki Y, Takano M, Tojo T, Homma M. Mixed connective tissue disease with pulmonary hypertension: A clinical and pathologic study. J Rheumatol 1987; 14: 826–830.PubMedGoogle Scholar
  242. 241.
    Moutsopoulos HM, Chused TM, Mann DL, et al. Sjögren’s syndrome (sicca syndrome): Current issues. Ann Intern Med 1980; 92: 212–226.PubMedGoogle Scholar
  243. 242.
    Fox RI, Howell FV, Bone RC, Michelson P. Primary Sjögren syndrome: Clinical and immunopathologic features. Semin Arthritis Rheum 1984; 14: 77–105.PubMedGoogle Scholar
  244. 243.
    Fox RI, Robinson CA, Curd JG, Kozin F, Howell FV. Sjögren’s syndrome: Proposed criteria for classification. Arthritis Rheum 1986; 29: 577–585.PubMedGoogle Scholar
  245. 244.
    Strimlan CV, Rosenow EC, III, Divertie MB, Harrison EG. Pulmonary manifestations of Sjögren’s syndrome. Chest 1976; 70: 354–361.PubMedGoogle Scholar
  246. 245.
    Fairfax AJ, Haslam PL, Pavia D, et al. Pulmonary disorders associated with Sjögren’s syndrome. Q J Med 1981; 50: 279–295.PubMedGoogle Scholar
  247. 246.
    Constantopolous SH, Papadimitriou CS, Moutsopoulos HM. Respiratory manifestations in primary Sjögren’s syndrome. Chest 1985; 88: 226–229.Google Scholar
  248. 247.
    Papathanasiou MP, Constantopoulos SH, Tsampoulas C, Drosis AA, Moutsopoulos HM. Reappraisal of respi- ratory abnormalities in primary and secondary Sjögren’s syndrome: A controlled study. Chest 1986; 90: 370–374.PubMedGoogle Scholar
  249. 248.
    Constantopolous SH, Moutsopoulos HM. Respiratory involvement in patients with Sjögren’s syndrome: Is it a problem? Scand J Rheumatol 1986;Suppl 61: 146–150.Google Scholar
  250. 249.
    Hatron PY, Wallaert B, Gosset D, et al. Subclinical lung inflammation in primary Sjögren’s syndrome: Relationship between bronchoalveolar lavage cellular analysis findings and characteristics of disease. Arthritis Rheum 1987; 30: 1226–1231.PubMedGoogle Scholar
  251. 250.
    Gudbjörnsson B, Hedenström H, Stâlenheim G, Hällgren R. Bronchial hypersensitiveness to metacholine in patients with primary Sjögren’s syndrome. Ann Rheum Dis 1991;50:36– 40.Google Scholar
  252. 251.
    Dalavanga YA, Constantopoulos SH, Galanopoulou V, Zerva L, Moutsopoulos HM. Alveolitis correlates with clinical pulmonary involvement in primary Sjögren’s syndrome. Chest 1991; 99: 1394–1397.PubMedGoogle Scholar
  253. 252.
    Hansen LA, Prakash UBS, Colby TV. Pulmonary lymphoma in Sjögren’s syndrome. Mayo Clin Proc 1989; 64: 920–931.PubMedGoogle Scholar
  254. 253.
    Case records of the Massachusetts General Hospital, case 28–1975. N Engl J Med 1975; 293: 136–144.Google Scholar
  255. 254.
    Ferreiro JE, Robalino BO, Saldana MJ. Primary Sjögren’s syndrome with diffuse cerebral vasculitis and lymphocytic interstitial pneumonitis. Am J Med 1987; 82: 1227–1232.PubMedGoogle Scholar
  256. 255.
    McGuigan LE, Geczy AF, Edmonds JP. The immunopathology of ankylosing spondylitis-a review. Semin Arthritis Rheum 1985; 15: 81–105.PubMedGoogle Scholar
  257. 256.
    van der Linden S, Valkenburg H, Cats A. The risk of developing ankylosing spondylitis in HLA-B27 positive individuals: A family and population study. Br J Rheumatol 1983; 22 (Suppl 2): 18–19.PubMedGoogle Scholar
  258. 257.
    Hamilton KA. Pulmonary disease manifestations of ankylosing spondylitis. Ann Intern Med 1949; 31: 216–227.PubMedGoogle Scholar
  259. 258.
    Dunham CL, Kautz FG. Spondylartritis ankylopoietica: A review and report of twenty cases. Am J Med Sci 1941; 201: 232–250.Google Scholar
  260. 259.
    Campbell AH, MacDonald CB. Upper lobe fibrosis associated with ankylosing spondylitis. Br J Dis Chest 1965; 59: 90–101.PubMedGoogle Scholar
  261. 260.
    Davies D. Ankylosing spondylitis and lung fibrosis. Q J Med 1972; 41: 395–417.PubMedGoogle Scholar
  262. 261.
    Vale JA, Pickering JG, Scott GW. Ankylosing spondylitis and upper fibrosis and cavitation. Guys Hosp Rep 1974; 123: 97–119.PubMedGoogle Scholar
  263. 262.
    Rosenow EC, III, Strimlan CV, Muhm JR, Ferguson RH. Pleuropulmonary manifestations of ankylosing spondylitis. Mayo Clin Proc 1977; 52: 641–649.PubMedGoogle Scholar
  264. 263.
    Hurwitz SS, Cohen AA, Krige LP. Fibrocavitating pul monary lesions in ankylosing spondylitis. S Afr Med J 1982; 61: 168–170.PubMedGoogle Scholar
  265. 264.
    Hillderdal G. Ankylosing spondylitis lung disease: An underdiagnosed entity. Eur J Respir Dis 1983; 64: 437–441.Google Scholar
  266. 265.
    Rumancik WM, Firooznia H, Davis MS, Jr., et al. Fibrobullous disease of the upper lobes: An extraskeletal manifestation of ankylosing spondylitis. J Comput Tomogr 1984; 8: 225–229.PubMedGoogle Scholar
  267. 266.
    Boushea DK, Sundstrom WR. The pleuropulmonary manifestations of ankylosing spondylitis. Semin Arthritis Rheum 1989; 18: 277–281.PubMedGoogle Scholar
  268. 267.
    Sharp JT, Sweany SK, Henry JP, et al. Lung and thoracic compliances in ankylosing spondylitis. J Lab Clin Med 1964; 63: 254–263.PubMedGoogle Scholar
  269. 268.
    Elliot CG, Hill TR, Adams TE, et al. Exercise performance of subjects with ankylosing spondylitis and limited chest expansion. Bull Eur Physiopathol Respir 1985; 21: 363–368.Google Scholar
  270. 269.
    Feltelius N, Hedenstrom H, Hillerdal G, Hallgren R. Pulmonary involvement in ankylosing spondylitis. Ann Rheum Dis 1986; 45: 736–740.PubMedGoogle Scholar
  271. 270.
    Franssen MJ, van Herwaarden CL, van de Putte LB, Gribnau FW. Lung function in patients with ankylosing spondylitis: A study of the influence of disease activity and treatment with nonsteroidal anti-inflammatory drugs. J Rheumatol 1986; 13: 936–940.PubMedGoogle Scholar
  272. 271.
    Cohen AA, Natelson EA, Fechner RE. Fibrosing interstitial pneumonitis in ankylosing spondylitis. Chest 1971; 59: 369–371.PubMedGoogle Scholar
  273. 272.
    Appelrouth D, Gottlieb NL. Pulmonary manifestations of ankylosing spondylitis. J Rheumatol 1975; 2: 446–453.PubMedGoogle Scholar
  274. 273.
    Pearson CM, Kline HM, Newcomer VD. Relapsing polychondritis. N Engl J Med 1960; 263: 51–58.PubMedGoogle Scholar
  275. 274.
    Dolan DL, Lemmon GB, Teitelbaum SL. Relapsing polychondritis: Analytical literature review and studies on pathogenesis. Am J Med 1966; 41: 285–299.PubMedGoogle Scholar
  276. 275.
    Hughes RAC, Berry CL, Seifert M, Lessof MH. Relapsing polychondritis: Three cases with a clinicopathological study and literature review. Q J Med 1972; 41: 363–380.PubMedGoogle Scholar
  277. 276.
    Arkin CR, Masi AT. Relapsing polychondritis: Review of current status and case report. Semin Arthritis Rheum 1975; 5: 41–62.PubMedGoogle Scholar
  278. 277.
    McAdam LP, O’Hanlan MA, Bluestone R, Pearson CM. Relapsing polychondritis: Prospective study of 23 patients and a review of the literature. Medicine (Baltimore) 1976; 55: 193–215.Google Scholar
  279. 278.
    Giroux L, Paquin F, Guérard-Desjardins MJ, Lefaivre A. Relapsing polychondritis: An autoimmune disease. Semin Arthritis Rheum 1983; 13: 182–187.Google Scholar
  280. 279.
    Michet CJ, Jr., McKenna CH, Luthra HS, O’Fallon WM. Relapsing polychondritis: Survival and predictive role of early disease manifestations. Ann Intern Med 1986; 104: 74–78.PubMedGoogle Scholar
  281. 280.
    Eng J, Sabanathan S. Airway complications in relapsing polychondritis. Ann Thorac Surg 1991; 51: 686–692.PubMedGoogle Scholar
  282. 281.
    Jaksch-Wartenhorst R. Polychondropathia. Wien Arch Intern Med 1923; 6: 93–100.Google Scholar
  283. 282.
    Atherr F. Uber einen Fall von systematiseirter Chondromacie. Virchows Arch A Pathol Anat Histol 1936; 297: 445–479.Google Scholar
  284. 283.
    von Meyerburg R. Ueber chondromacie. Schweiz Med Wochenschr 1936; 17: 1239–1240.Google Scholar
  285. 284.
    Gibson GJ, Davis P. Respiratory complications of relapsing polychondritis. Thorax 1974; 29: 726–731.PubMedGoogle Scholar
  286. 285.
    Mohsenifar Z, Tashkin DP, Carson SA, Bellamy PE. Pulmonary function in patients with relapsing polychondritis. Chest 1982; 81: 711–727.PubMedGoogle Scholar
  287. 286.
    Kovarsky J. Otorhinolaryngologic complications of rheumatic diseases. Semin Arthritis Rheum 1984; 14: 141–150.PubMedGoogle Scholar
  288. 287.
    White JW. Relapsing polychondritis. South Med J 1985; 78: 448–451.PubMedGoogle Scholar
  289. 288.
    Krell WS, Staats BA, Hyalt RE. Pulmonary function in relapsing polychondritis. Am Rev Respir Dis 1986; 133: 1120–1123.PubMedGoogle Scholar
  290. 289.
    Svenson KLG, Holmdahl R, Klareskog L, et al. Cyclosporin A treatment in a case of relapsing polychondritis. Scand J Rheumatol 1984; 13: 329–333.PubMedGoogle Scholar
  291. 290.
    Neilly JB, Winter JH, Stevenson RD. Progressive tracheobronchial polychondritis: Need for early diagnosis. Thorax 1985; 40: 78–79.PubMedGoogle Scholar
  292. 291.
    Crockford MP, Kerr IH. Relapsing polychondritis. Clin Radiol 1988; 39: 386–390.PubMedGoogle Scholar
  293. 292.
    Lipnick RN, Fink CW. Acute airway obstruction in relapsing polychondritis: Treatment with pulse methylprednisolone. J Rheumatol 1991; 18: 98–99.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1994

Authors and Affiliations

  • J. T. Lie

There are no affiliations available

Personalised recommendations